The bill is a must-pass piece of legislation because it extends the 20-year program that helps fund the FDA's budget for reviewing new drugs and medical implants.http://feeds.feedburner.com/~r/jems/thelatest/~4/pDaYOmKVvEs
View the full article
No replies to this topic
0 user(s) are reading this topic
0 members, 0 guests, 0 anonymous users
